Trials / Completed
CompletedNCT05342597
Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effect of food on the pharmacokinetics of oral edaravone in healthy adult subjects. In this study, we determined 5 different dietary conditions including 4 different meal contents and fasting condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-1186 | A crossover study in which Japanese healthy subjects receive a single dose of MT-1186 under several dosing condition on Day 1, 3, 5, 7 and 24 according to their treatment sequence. |
Timeline
- Start date
- 2019-06-10
- Primary completion
- 2019-07-24
- Completion
- 2019-07-24
- First posted
- 2022-04-22
- Last updated
- 2026-01-07
- Results posted
- 2024-01-05
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05342597. Inclusion in this directory is not an endorsement.